title: Anti-tumour necrosis factor α-induced lupus erythematosus panniculitis.
authors.affiliation: Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin disorders, Hôpital Saint-André, 1, rue Jean Burguet, 33000, Bordeaux, France.
authors.forename: A-L
authors.initials: AL
authors.lastname: Durand
authors.affiliation: Department of Pathology, Hôpital Haut-Lévêque, avenue Magellan, 33600, Pessac, France.
authors.forename: J-F
authors.initials: JF
authors.lastname: Goussot
authors.affiliation: Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin disorders, Hôpital Saint-André, 1, rue Jean Burguet, 33000, Bordeaux, France.
authors.forename: D
authors.initials: D
authors.lastname: Thiolat
authors.affiliation: Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin disorders, Hôpital Saint-André, 1, rue Jean Burguet, 33000, Bordeaux, France.
authors.forename: A
authors.initials: A
authors.lastname: Taieb
authors.affiliation: Department of Dermatology, Centre hospitalier de Périgueux, 80, avenue Georges Pompidou, 24000, Périgueux, France.
authors.forename: J
authors.initials: J
authors.lastname: Marie
authors.affiliation: Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin disorders, Hôpital Saint-André, 1, rue Jean Burguet, 33000, Bordeaux, France.
authors.forename: J
authors.initials: J
authors.lastname: Seneschal
authors.affiliation: Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin disorders, Hôpital Saint-André, 1, rue Jean Burguet, 33000, Bordeaux, France.
authors.forename: A-S
authors.initials: AS
authors.lastname: Darrigade
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D015435:Panniculitis, Lupus Erythematosus / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab